APCDD1 was first identified as a direct Wnt target of the β-catenin/TCF4 transcription complex by Takahashi et al. who further reported increased APCDD1 expression in primary colon cancer tissue compared with corresponding healthy tissue [25]. The gene discussed is TCF4; the disease is malignant colon neoplasm.